Synopsis: Godavari Biorefineries received a US patent for anti-cancer compounds targeting stem cells in breast/prostate cancers, granting exclusive rights to develop and produce them, boosting oncology research.

This Chemical stock, engaged in integrated biorefinery operations producing sugar, ethanol, bio-based chemicals, and power from sugarcane across facilities in Karnataka and Maharashtra, jumped 17.14 percent after securing a US patent for new anti-cancer compounds.

With a market capitalization of Rs. 1,267.12 crores, the share of Godavari Biorefineries Limited has reached an intraday high of Rs. 280.85 per equity share, rising nearly 17.14 percent from its previous day’s close price of Rs. 239.75. Since then, the stock has retreated and is currently trading at Rs. 247.60 per e

See Full Page